2636 Outcomes and drug costs associated with alternate sunitinib dosing regimens in mRCC

Autor: Suo, A., Iqbal, U., Lim, J., Lee, C., Gesy, K., Bryce, R., Abbas, T., Iqbal, N.
Zdroj: In European Journal of Cancer September 2015 51 Supplement 3:S525-S525
Databáze: ScienceDirect
Externí odkaz: